Response to “Systemic Bevacizumab for Hereditary Hemorrhagic Telangiectasia

Considerations from Observational Studies”

研究成果: 雜誌貢獻快報

原文英語
頁(從 - 到)369-370
頁數2
期刊Otolaryngology - Head and Neck Surgery (United States)
160
發行號2
DOIs
出版狀態已發佈 - 二月 1 2019

指紋

Hereditary Hemorrhagic Telangiectasia
Observational Studies
Bevacizumab

ASJC Scopus subject areas

  • Surgery
  • Otorhinolaryngology

引用此文

@article{2dfad6cd2ebc48d5a30b3a3e8d1484a8,
title = "Response to “Systemic Bevacizumab for Hereditary Hemorrhagic Telangiectasia: Considerations from Observational Studies”",
author = "Hsu, {Yuan Pin} and Hsu, {Chin Wang} and Chiehfeng Chen",
year = "2019",
month = "2",
day = "1",
doi = "10.1177/0194599818813522",
language = "English",
volume = "160",
pages = "369--370",
journal = "Otolaryngology - Head and Neck Surgery",
issn = "0194-5998",
publisher = "Mosby Inc.",
number = "2",

}

TY - JOUR

T1 - Response to “Systemic Bevacizumab for Hereditary Hemorrhagic Telangiectasia

T2 - Considerations from Observational Studies”

AU - Hsu, Yuan Pin

AU - Hsu, Chin Wang

AU - Chen, Chiehfeng

PY - 2019/2/1

Y1 - 2019/2/1

UR - http://www.scopus.com/inward/record.url?scp=85061305764&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85061305764&partnerID=8YFLogxK

U2 - 10.1177/0194599818813522

DO - 10.1177/0194599818813522

M3 - Letter

VL - 160

SP - 369

EP - 370

JO - Otolaryngology - Head and Neck Surgery

JF - Otolaryngology - Head and Neck Surgery

SN - 0194-5998

IS - 2

ER -